SCHEMBL16454854

SCHEMBL16454854

CCc1ccccc1NC(=O)c1cccn2c(-c3ccccc3F)nnc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ RXFP1 Q9HBX9 2/20 0.55
▸ KMT2A Q03164 4/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ HTT P42858 1/20 0.42
▸ HPGD P15428 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ MAPT P10636 3/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ PDE2A O00408 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ SMO Q99835 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16454856 0.85 NPC1 (0.50) TP53LMNARXFP1KMT2AMEN1
SCHEMBL16454871 0.83 MEN1 (0.48) TP53LMNARXFP1KMT2AMEN1
SCHEMBL16454872 0.83 IDO1 (0.49) TP53LMNAKMT2AKDM4EMEN1
SCHEMBL16454819 0.79 HPGD (0.54) KMT2AALDH1A1KDM4EHTTHPGD
SCHEMBL16454790 0.74 KMT2A (0.44) KMT2AMEN1NPC1RAB9A
SCHEMBL16454788 0.74 POLB (0.60) LMNAKMT2AALDH1A1KDM4EHTT
SCHEMBL16454784 0.73 TSHR (0.46) TP53LMNARXFP1KMT2AALDH1A1
SCHEMBL16454851 0.72 LMNA (0.43) TP53LMNARXFP1KMT2AALDH1A1
SCHEMBL16454827 0.72 IDO1 (0.48) LMNARXFP1KMT2AALDH1A1KDM4E
SCHEMBL9844298 0.71 PDE2A (0.47) ALDH1A1KDM4EHPGDSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015020565-A1 SUBSTITUTED [1,2,4]TRIAZOLO[4,3-A]PYRIDINES EXHIBITING ANTAGONIST PROPERTIES TO ADENOSINE A2A RECEPTORS, AND USE THEREOF ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НЬЮВАК" (ООО "НЬЮВАК") (RU) 2015-02-12 — — WO disclosed
Send feedback